BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35921545)

  • 21. ZNF384-fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activities.
    Yamamoto H; Hayakawa F; Yasuda T; Odaira K; Minamikawa Y; Tange N; Hirano D; Kojima Y; Morishita T; Tsuzuki S; Naoe T; Kiyoi H
    FEBS Lett; 2019 Aug; 593(16):2151-2161. PubMed ID: 31234226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
    Hou Z; Ren Y; Zhang X; Huang D; Yan F; Sun W; Zhang W; Zhang Q; Fu X; Lang Z; Chu C; Zou B; Gao B; Jin B; Kang Z; Liu Q; Yan J
    Cell Commun Signal; 2024 Apr; 22(1):211. PubMed ID: 38566191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of Clinical Characteristics of Acute B Lymphoblastic Leukemia with EP300-ZNF384 Fusion Gene Positive].
    Yao ZL; Li YF; Li M; Li Y; Li WJ; Li HH; Liu YY; Lin SH; Li FW; Zhang J; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):24-28. PubMed ID: 32027248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12).
    Nyquist KB; Thorsen J; Zeller B; Haaland A; Trøen G; Heim S; Micci F
    Cancer Genet; 2011 Mar; 204(3):147-52. PubMed ID: 21504714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Adult Patient with Early Pre-B Acute Lymphoblastic Leukemia with t(12;17)(p13;q21)/ZNF384-TAF15.
    Georgakopoulos N; Diamantopoulos P; Micci F; Giannakopoulou N; Zervakis K; Dimitrakopoulou A; Viniou NA
    In Vivo; 2018; 32(5):1241-1245. PubMed ID: 30150451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report.
    Sun K; Wang J; Chen WM; Xu N; Long LY; Wang X; Jiang H; Jiang Q; Huang XJ; Qin YZ
    Biomol Biomed; 2023 Mar; 23(2):298-309. PubMed ID: 36124444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL
    Weinberg OK; Dennis J; Zia H; Chen P; Chu A; Koduru P; Luu HS; Fuda F; Chen W
    Int J Lab Hematol; 2023 Apr; 45(2):170-178. PubMed ID: 36325594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.
    Chang TY; Chen SH; Jaing TH; Yang SH; Wen YC; Yang CP; Hung IJ
    Pediatr Neonatol; 2021 Jan; 62(1):21-25. PubMed ID: 32859541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia.
    Zhao X; Wang P; Diedrich JD; Smart B; Reyes N; Yoshimura S; Zhang J; Yang W; Barnett K; Xu B; Li Z; Huang X; Yu J; Crews K; Yeoh AEJ; Konopleva M; Wei CL; Pui CH; Savic D; Yang JJ
    Nat Commun; 2022 Sep; 13(1):5401. PubMed ID: 36104354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of TCF3-ZNF384 fusion by transcriptome sequencing in B cell acute lymphoblastic leukemia and its laboratory and clinical characteristics].
    Wu Q; Wang F; Yang J; Chen X; Ma X; Cao P; Zhang Y; Nie D; Chen J; Zhou X; Fang J; Liu M; Zhang M; Wu P; Wang T; Liu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Apr; 38(4):351-354. PubMed ID: 33834463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.
    Semchenkova A; Mikhailova E; Komkov A; Gaskova M; Abasov R; Matveev E; Kazanov M; Mamedov I; Shmitko A; Belova V; Miroshnichenkova A; Illarionova O; Olshanskaya Y; Tsaur G; Verzhbitskaya T; Ponomareva N; Bronin G; Kondratchik K; Fechina L; Diakonova Y; Vavilova L; Myakova N; Novichkova G; Maschan A; Maschan M; Zerkalenkova E; Popov A
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
    Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
    Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
    Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
    Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia.
    Kim J; Kim HS; Shin S; Lee ST; Choi JR
    Ann Lab Med; 2016 Jul; 36(4):396-8. PubMed ID: 27139620
    [No Abstract]   [Full Text] [Related]  

  • 40. The genetic basis and cell of origin of mixed phenotype acute leukaemia.
    Alexander TB; Gu Z; Iacobucci I; Dickerson K; Choi JK; Xu B; Payne-Turner D; Yoshihara H; Loh ML; Horan J; Buldini B; Basso G; Elitzur S; de Haas V; Zwaan CM; Yeoh A; Reinhardt D; Tomizawa D; Kiyokawa N; Lammens T; De Moerloose B; Catchpoole D; Hori H; Moorman A; Moore AS; Hrusak O; Meshinchi S; Orgel E; Devidas M; Borowitz M; Wood B; Heerema NA; Carrol A; Yang YL; Smith MA; Davidsen TM; Hermida LC; Gesuwan P; Marra MA; Ma Y; Mungall AJ; Moore RA; Jones SJM; Valentine M; Janke LJ; Rubnitz JE; Pui CH; Ding L; Liu Y; Zhang J; Nichols KE; Downing JR; Cao X; Shi L; Pounds S; Newman S; Pei D; Guidry Auvil JM; Gerhard DS; Hunger SP; Inaba H; Mullighan CG
    Nature; 2018 Oct; 562(7727):373-379. PubMed ID: 30209392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.